A novel anti-inflammatory role for spleen-derived interleukin-10 in obesity-induced inflammation in white adipose tissue and liver

Diabetes

Volumn 61, Issue 8, 2012, Pages 1994-2003

  Gotoh, Koro ^a   Inoue, Megumi ^a   Masaki, Takayuki ^a   Chiba, Seiichi ^a   Shimasaki, Takanobu ^a   Ando, Hisae ^a   Fujiwara, Kansuke ^a   Katsuragi, Isao ^a   Kakuma, Tetsuya ^a   Seike, Masataka ^a   Sakata, Toshiie ^a   Yoshimatsu, Hironobu ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAT; INTERLEUKIN 10; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CATABOLISM; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GLUCOSE METABOLISM; HEPATITIS; HISTOPATHOLOGY; HYPOPHAGIA; LIPID DIET; LIPID METABOLISM; LIPID STORAGE; LIVER; MALE; MOUSE; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPLEEN; SPLENECTOMY; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ANIMALS; DIET, HIGH-FAT; EATING; HEPATITIS; INFLAMMATION; INTERLEUKIN-10; LIPID METABOLISM; MALE; MICE; MICE, KNOCKOUT; OBESITY; SPLEEN; SPLENECTOMY;

EID: 84864390324     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1688     Document Type: Article

References (28)

1. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-1119 (Pubitemid 40629025)
2. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444: 860-867 (Pubitemid 46024993)
3. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006;116:1793-1801 (Pubitemid 44033299)
4. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest 2011;121:2111-2117
5. Kaminski DA, Randall TD. Adaptive immunity and adipose tissue biology. Trends Immunol 2010;31:384-390
6. Yin M,Wheeler MD, Kono H, et al. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 1999;117:942-952 (Pubitemid 29468238)
7. Lin HZ, Yang SQ, Chuckaree C, Kuhajda F, Ronnet G, Diehl AM. Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med 2000;6: 998-1003
8. Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006;116:1494-1505
9. Lamas O, Martínez JA, Marti A. Decreased splenic mRNA expression levels of TNF-alpha and IL-6 in diet-induced obese animals. J Physiol Biochem 2004;60:279-283
10. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004;22:929-979 (Pubitemid 38680445)
11. Esposito K, Pontillo A, Giugliano F, et al. Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocrinol Metab 2003;88:1055-1058 (Pubitemid 36337756)
12. Waters KA, Mast BT, Vella S, et al. Structural equation modeling of sleep apnea, inflammation, and metabolic dysfunction in children. J Sleep Res 2007;16:388-395 (Pubitemid 350153623)
13. Sakata T. Hunger and satiety related activity induced certain metabolites in rats. In The Neural Basis of Feeding and Reward. Hoebel BG, Ed. Brunswick, ME, Haer Institute for Electrophysiological Research, 1982, p. 339-354
14. Cai D, Yuan M, Frantz DF, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 2005;11:183-190 (Pubitemid 40321354)
15. Segersvärd R, Tsai JA, Herrington MK, Wang F. Obesity alters cytokine gene expression and promotes liver injury in rats with acute pancreatitis. Obesity (Silver Spring) 2008;16:23-28 (Pubitemid 351271945)
16. Barbuio R, Milanski M, Bertolo MB, Saad MJ, Velloso LA. Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet. J Endocrinol 2007;194:539-550 (Pubitemid 47471222)
17. Fatouros M, Bourantas K, Bairaktari E, Elisaf M, Tsolas O, Cassioumis D. Role of the spleen in lipid metabolism. Br J Surg 1995;82:1675-1677
18. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-274 (Pubitemid 23320290)
19. Altunkaynak BZ, Ozbek E, Altunkaynak ME. A stereological and histological analysis of spleen on obese female rats, fed with high fat diet. Saudi Med J 2007;28:353-357 (Pubitemid 46605052)
20. Gotoh K, Inoue M, Masaki T, et al. A novel anti-inflammatory role for spleen-derived interleukin-10 in obesity-induced hypothalamic inflammation. J Neurochem 2012;120:752-764
21. Sato Mito N, Suzui M, Yoshino H, Kaburagi T, Sato K. Long term effects of high fat and sucrose diets on obesity and lymphocyte proliferation in mice. J Nutr Health Aging 2009;13:602-606
22. Hollis JH, Lemus M, Evetts MJ, Oldfield BJ. Central interleukin-10 attenuates lipopolysaccharide-induced changes in food intake, energy expenditure and hypothalamic Fos expression. Neuropharmacology 2010;58: 730-738
23. Ropelle ER, Flores MB, Cintra DE, et al. IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKbeta and ER stress inhibition. PLoS Biol 2010;8:e1000465
24. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91 (Pubitemid 23036092)
25. Zhang LJ, Zheng WD, Chen YX, et al. Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis. Hepatogastroenterology 2007;54:2092-2098
26. Cintra DE, Pauli JR, Araújo EP, et al. Interleukin-10 is a protective factor against diet-induced insulin resistance in liver. J Hepatol 2008;48:628-637
27. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 2004;323:630-635 (Pubitemid 39221142)
28. Huang W, Metlakunta A, Dedousis N, et al. Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes 2010;59:347-357